Orthofix Medical
OFIX
162 hedge funds and large institutions have $1.05B invested in Orthofix Medical in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 54 reducing their positions, and 26 closing their positions.
1.44% more ownership
Funds ownership: 94.9% → 96.34% (+1.4%)
4% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 54
4% more capital invested
Capital invested by funds: $1.02B → $1.05B (+$36.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
1% less funds holding
Funds holding: 163 → 162 (-1)
7% less call options, than puts
Call options by funds: $2.25M | Put options by funds: $2.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$11.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.94M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$6.25M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$5.1M |
| 5 |
BlackRock
New York
|
+$4.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$11.4M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$10.9M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$5.69M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$5.32M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$4.14M |
OFIX Hedge Fund Activity: Q3 2018 in Review
162 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q3 2018, worth a combined $1.05B — up 3.5% from $1.02B a quarter earlier.
Fund positioning in OFIX was balanced in Q3 2018: 26 funds opened new positions, 26 closed out, 56 added to existing stakes and 54 trimmed.
The largest buyer was Rothschild & Co Asset Management US, opening a new position worth an estimated $11.8M. The largest seller was Diamond Hill Capital Management, cutting an estimated $11.4M.
- 162 institutional investors held Orthofix Medical (OFIX) as of Q3 2018, down from 163 in Q2 2018.
- Funds reported $1.05B of Orthofix Medical stock for Q3 2018, up 3.5% quarter-over-quarter.
- 26 funds opened new Orthofix Medical positions in Q3 2018 and 26 closed out, a net change of 0 holders.
- The largest Orthofix Medical buyer in Q3 2018 was Rothschild & Co Asset Management US, an estimated $11.8M added.
- The largest Orthofix Medical seller in Q3 2018 was Diamond Hill Capital Management, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2018.